ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 751 filers reported holding ASTRAZENECA PLC in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,849,137 | +20.1% | 4,058,611 | +27.0% | 1.20% | +23.1% |
| Q2 2023 | $228,801,346 | +16.3% | 3,196,889 | +12.8% | 0.98% | +1.0% |
| Q1 2023 | $196,728,485 | +20.9% | 2,834,296 | +18.1% | 0.97% | -2.6% |
| Q4 2022 | $162,765,019 | +41.4% | 2,400,664 | +14.4% | 0.99% | +35.1% |
| Q3 2022 | $115,111,000 | -0.0% | 2,099,032 | +20.4% | 0.74% | +5.6% |
| Q2 2022 | $115,160,000 | +66.8% | 1,743,006 | +51.6% | 0.70% | +85.6% |
| Q3 2021 | $69,033,000 | -22.3% | 1,149,393 | -22.5% | 0.38% | -25.1% |
| Q2 2021 | $88,802,000 | +52.8% | 1,482,494 | +26.8% | 0.50% | +37.3% |
| Q1 2021 | $58,132,000 | +73.8% | 1,169,181 | +84.8% | 0.36% | +24.1% |
| Q2 2020 | $33,456,000 | +306.0% | 632,551 | +282.7% | 0.29% | +297.3% |
| Q4 2019 | $8,241,000 | -85.2% | 165,275 | -86.8% | 0.07% | -87.1% |
| Q3 2019 | $55,723,000 | +162.9% | 1,250,242 | +143.5% | 0.57% | +112.6% |
| Q2 2019 | $21,192,000 | – | 513,366 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |